Wantanwa Krongrawa

Mr. Wantanwa Krongrawa

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
WKWantanwa Krongrawa
Wantanwa Krongrawa
WAWah Wah Aung
Wah Wah Aung
NCNawinda Chinatangkul
Nawinda Chinatangkul
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
The present review explores the growing interest in the techniques employed for extracting natural products. It emphasizes the limitations of conventional extraction methods and introduces superior non-conventional alternatives, particularly ultrasound-assisted extraction. Characterization and quantification of bioactive constituents through chromatography coupled with spectroscopy are recommended, while the importance of method development and validation for biomarker quantification is underscored. At present, electrospun fibers provide a versatile platform for incorporating bioactive extracts and have extensive potential in diverse fields due to their unique structural and functional characteristics. Thus, the review also highlights the fabrication of electrospun fibers containing bioactive extracts. The preparation of biologically active extracts under optimal conditions, including the selection of safe solvents and cost-effective equipment, holds promising potential in the pharmaceutical, food, and cosmetic industries. Integration of experimental design into extraction procedures and formulation development is essential for the efficient production of health products. The review explores potential applications of encapsulating natural product extracts in electrospun fibers, such as wound healing, antibacterial activity, and antioxidant properties, while acknowledging the need for further exploration and optimization in this field. The findings discussed in this review are anticipated to serve as a valuable resource for the processing industry, enabling the utilization of affordable and environmentally friendly, natural, and raw materials.

29 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
WKWantanwa Krongrawa
Wantanwa Krongrawa
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
MVMont Kumpugdee Vollrath
Mont Kumpugdee Vollrath
PKPrasat Kittakoop
Prasat Kittakoop
SSSupachai Saibua
Supachai Saibua
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
This study aimed to develop a Kaempferia parviflora (KP) extract based on electrospun shellac fibers capable of transporting methoxyflavones. This study used a Box–Behnken design to determine the optimal production parameters that influence the fiber diameter and bead-to-fiber ratio responses. The optimization step produced fibers with a small diameter (574 nm) and a lower bead-to-fiber ratio (0.48 beads per fiber) by combining 37.25% w/w shellac and 1.50% w/w KP extract with a solution feed rate of 0.8 mL/h and an electrical voltage of 18 kV. The KP extract was found to be dispersed throughout the electrospun shellac fibers during the characterization study. The results were highly correlated with the theoretical values, indicating that the regression models used to predict the response variables were adequate. A study of in vitro dissolution confirmed that KP extract-loaded electrospun shellac fibers could produce a sustained-release profile within 10 h. Additionally, KP-infused shellac fibers demonstrated antibacterial activity against Staphylococcus aureus. This KP loading method combined with shellac properties provided a new delivery system and could be used to explore novel biomedical materials.

16 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
WAWah Wah Aung
Wah Wah Aung
KPKanokpon Panich
Kanokpon Panich
SWSuchawalee Watthanophas
Suchawalee Watthanophas
SNSutada Naridsirikul
Sutada Naridsirikul
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
Senna alata leaves display various biological activities as a result of their rhein and phenolic composition. The objective of this study was to develop bioactive de-chlorophyll rhein-rich S. alata extracts. The rhein content was quantified using a validated high-performance liquid chromatography–diode array detection (HPLC–DAD) method. The best process parameters for maximizing rhein were established using ultrasound-assisted extraction (UAE). The optimal conditions for the parameters were determined using the Box–Behnken design (BBD); 95% v/v ethanol was used as the extraction solvent at 59.52 °C for 18.4 min with a solvent-to-solid ratio of 25.48:1 (mL/g) to obtain the predicted value of rhein at 10.44 mg/g extract. However, the color of the rhein-rich extract remained dark brown. For the removal of chlorophyll, liquid–liquid extraction with vegetable oils and adsorption with bleaching agents were employed. The bleaching agents were significantly more effective at removing chlorophyll and had less of an effect on the reduction in rhein content than vegetable oils. The presence of rhein and phenolics in the de-chlorophyll extracts might be responsible for their antioxidant, anti-inflammatory, and antibacterial activities. These findings indicate that rhein-rich extract and its de-chlorophyll extracts possess sufficient biological activities for the further development of cosmeceuticals and pharmaceuticals.

8 January 2024 in Polymers
Verified
Journal Article
Open access
PDF file
WAWah Wah Aung
Wah Wah Aung
WKWantanwa Krongrawa
Wantanwa Krongrawa
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
PKPattranit Kulpicheswanich
Pattranit Kulpicheswanich
SOSiriporn Okonogi
Siriporn Okonogi
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
Single-fluid electrospinning creates nanofibers from molten polymer solutions with active ingredients. This study utilized a combination of a fractional factorial design and a Box–Behnken design to examine crucial factors among a multitude of parameters and to optimize the electrospinning conditions that impact fiber mats’ morphology and the entrapment efficiency of Senna alata leaf extract. The findings indicated that the shellac content had the greatest impact on both fiber diameter and bead formation. The optimum electrospinning conditions were identified as a voltage of 24 kV, a solution feed rate of 0.8 mL/h, and a shellac–extract ratio of 38.5:3.8. These conditions produced nanosized fibers with a diameter of 306 nm, a low bead-to-fiber ratio of 0.29, and an extract entrapment efficiency of 96% within the fibers. The biphasic profile of the optimized nanofibers was confirmed with an in vitro release study. This profile consisted of an initial burst release of 88% within the first hour, which was succeeded by a sustained release pattern surpassing 90% for the next 12 h, as predicted with zero-order release kinetics. The optimized nanofibers demonstrated antimicrobial efficacy against diverse pathogens, suggesting promising applications in wound dressings and protective textiles.

8 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
WKWantanwa Krongrawa
Wantanwa Krongrawa
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
STSukannika Tubtimsri
Sukannika Tubtimsri
AJAkanitt Jittmittraphap
Akanitt Jittmittraphap
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
Background/Object: This study investigates the in vitro antiviral potential of D-limonene (DLM), monolaurin (ML), and cetylpyridinium chloride (CPC) in formulations targeting SARS-CoV-2 and influenza viruses. The aim was to develop oral and nasal formulations with optimized concentrations of these active ingredients to evaluate their efficacy, safety, and stability. Methods: Oral (formulation D) and nasal (formulation E) products were developed using specific concentrations of DLM (0.2–0.3% w/w), ML (0.1–0.2% w/w), and CPC (0.05–0.075% w/w). In vitro virucidal activity assays were conducted to assess the antiviral efficacy of the formulations against SARS-CoV-2 and influenza viruses. Stability testing was also performed under various storage conditions. Results: Formulation D (0.3% w/w DLM, 0.2% w/w ML, 0.05% w/w CPC, and 1.5% w/w Cremophor RH40) demonstrated a 3.875 ± 0.1021 log reduction and 99.99 ± 0.0032% efficacy against SARS-CoV-2 within 120 s. Formulation E (0.2% w/w DLM, 0.05% w/w CPC, and 0.75% w/w Cremophor RH40) showed a 2.9063 ± 0.1197 log reduction and 99.87 ± 0.0369% efficacy against SARS-CoV-2. Both formulations achieved >99.99% efficacy and log reductions exceeding 4.000 against various influenza strains. Stability testing confirmed optimal performance at 4 °C with no microbial contamination. Conclusions: The findings suggest that both formulations exhibit broad-spectrum antiviral activity against SARS-CoV-2 and influenza viruses in vitro. These results support their potential for further clinical evaluations and therapeutic applications, particularly in oral and nasal spray formulations.

12 December 2025 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
WKWantanwa Krongrawa
Wantanwa Krongrawa
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
This study optimized ultrasound-assisted extraction (UAE) conditions to maximize bioactive compounds from Momordica charantia L. (Okinawan bitter melon) fruit using response surface methodology (RSM). A three-factor, three-level Box-Behnken design assessed the effects of acoustic intensity, duty cycle, and extraction time on extraction yield, total phenolic content (TPC), antioxidant activity (DPPH and FRAP assays), α-glucosidase inhibitory activity, and charantin content. Acoustic intensity had the greatest impact, followed by duty cycle and extraction time. The optimal conditions were 85 W·cm-2 acoustic intensity, 0.83 s-1 duty cycle, and 13.20 min extraction time, yielding 35.80 % extract, 847.91 mg GAE/100 g extract TPC, IC50 of DPPH at 119.08 µg/mL, FRAP value of 148.76 mg AAE/g extract, α-glucosidase inhibition of 41.60 mg acarbose/g extract, and charantin content of 5.83 mg/g extract. Experimental values closely matched predictions, confirming model validity. This optimized UAE method provides an efficient approach for extracting bioactive compounds from M. charantia L., ensuring high yield and biological activity. The findings offer valuable insights for industrial-scale extraction and potential applications in functional foods, pharmaceuticals, and nutraceuticals.